{"id":"https://openalex.org/W2947553355","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","title":"Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial.","display_name":"Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947553355","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","mag":"2947553355"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.tps2659","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://iris.unito.it/bitstream/2318/2010490/1/Pembrolizumab%20in%20MMR-proficient%20metastatic%20colorectal%20cancer%20pharmacologically%20primed%20to%20trigger%20dynamic%20hypermutation%20status_%20The%20ARETHUSA%20trial.%20_%20Journal%20of%20Clinical%20Oncology.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031031537","display_name":"Salvatore Siena","orcid":"https://orcid.org/0000-0002-2681-2846","observed_orcids":["https://orcid.org/0000-0002-2681-2846"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Salvatore Siena","raw_affiliation_strings":["Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030218831","display_name":"Andrea Sartore Bianchi","orcid":"https://orcid.org/0000-0003-0780-0409","observed_orcids":["https://orcid.org/0000-0003-0780-0409"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Sartore-Bianchi","raw_affiliation_strings":["Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059373658","display_name":"Nicola Personeni","orcid":"https://orcid.org/0000-0002-7995-272X","observed_orcids":["https://orcid.org/0000-0002-7995-272X"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nicola Personeni","raw_affiliation_strings":["Humanitas Research Hospital, Rozzano, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Research Hospital, Rozzano, Italy;","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079437223","display_name":"Filippo Pietrantonio","orcid":"https://orcid.org/0000-0002-8530-8420","observed_orcids":["https://orcid.org/0000-0002-8530-8420"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo Pietrantonio","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024586369","display_name":"Giovanni Germano","orcid":"https://orcid.org/0000-0003-1688-8684","observed_orcids":["https://orcid.org/0000-0003-1688-8684"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Germano","raw_affiliation_strings":["Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034278780","display_name":"Alessio Amatu","orcid":"https://orcid.org/0000-0001-5396-3378","observed_orcids":["https://orcid.org/0000-0001-5396-3378"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessio Amatu","raw_affiliation_strings":["Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109315317","display_name":"Emanuela Bonoldi","orcid":"https://orcid.org/0000-0002-1047-5005","observed_orcids":["https://orcid.org/0000-0002-1047-5005"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuela Bonoldi","raw_affiliation_strings":["Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006266882","display_name":"Emanuele Valtorta","orcid":"https://orcid.org/0000-0002-5087-6233","observed_orcids":["https://orcid.org/0000-0002-5087-6233"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Valtorta","raw_affiliation_strings":["Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032586288","display_name":"Ludovic Barault","orcid":"https://orcid.org/0000-0001-5227-5047","observed_orcids":["https://orcid.org/0000-0001-5227-5047"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ludovic Barault","raw_affiliation_strings":["Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004556147","display_name":"Federica Di Nicolantonio","orcid":"https://orcid.org/0000-0001-9618-2010","observed_orcids":["https://orcid.org/0000-0001-9618-2010"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Di Nicolantonio","raw_affiliation_strings":["Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031332948","display_name":"Giulia Siravegna","orcid":"https://orcid.org/0000-0002-7132-6484","observed_orcids":["https://orcid.org/0000-0002-7132-6484"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Siravegna","raw_affiliation_strings":["Department of Oncology, University of Torino, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University of Torino, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016649801","display_name":"Giovanni Crisafulli","orcid":"https://orcid.org/0000-0002-5511-1555","observed_orcids":["https://orcid.org/0000-0002-5511-1555"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Crisafulli","raw_affiliation_strings":["Department of Oncology, University of Torino, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, University of Torino, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065803904","display_name":"Lorenza Rimassa","orcid":"https://orcid.org/0000-0001-9957-3615","observed_orcids":["https://orcid.org/0000-0001-9957-3615"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorenza Rimassa","raw_affiliation_strings":["Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy;","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009935310","display_name":"Filippo de Braud","orcid":"https://orcid.org/0000-0003-0103-730X","observed_orcids":["https://orcid.org/0000-0003-0103-730X"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo G. De Braud","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100766578","display_name":"Armando Santoro","orcid":"https://orcid.org/0000-0003-1709-9492","observed_orcids":["https://orcid.org/0000-0003-1709-9492"]},"institutions":[{"id":"https://openalex.org/I4210163047","display_name":"IRCCS Humanitas Research Hospital","ror":"https://ror.org/05d538656","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210163047"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Armando Santoro","raw_affiliation_strings":["Humanitas Research Hospital, Rozzano (MI), Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Humanitas Research Hospital, Rozzano (MI), Italy;","institution_ids":["https://openalex.org/I4210163047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089852748","display_name":"Luca Lazzari","orcid":"https://orcid.org/0000-0001-6841-4240","observed_orcids":["https://orcid.org/0000-0001-6841-4240"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Lazzari","raw_affiliation_strings":["IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037560184","display_name":"Paolo Luraghi","orcid":"https://orcid.org/0000-0003-2379-5195","observed_orcids":["https://orcid.org/0000-0003-2379-5195"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Luraghi","raw_affiliation_strings":["IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003553378","display_name":"Nabil Amirouchene-Angelozzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nabil Amirouchene-Angelozzi","raw_affiliation_strings":["IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;","institution_ids":["https://openalex.org/I4210114103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064011158","display_name":"Alberto Bardelli","orcid":"https://orcid.org/0000-0003-1647-5070","observed_orcids":["https://orcid.org/0000-0003-1647-5070"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberto Bardelli","raw_affiliation_strings":["Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy;","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080269874","display_name":"Silvia Marsoni","orcid":"https://orcid.org/0000-0002-5361-7122","observed_orcids":["https://orcid.org/0000-0002-5361-7122"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Marsoni","raw_affiliation_strings":["IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IFOM - the FIRC Institute of Molecular Oncology, Milan, Italy;","institution_ids":["https://openalex.org/I4210114103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"TPS2659","last_page":"TPS2659"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7964000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7964000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.14589999616146088,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.048500001430511475,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9890000224113464},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8309999704360962},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.7099999785423279},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9409999847412109},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.746999979019165},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/o6-methylguanine-dna-methyltransferase","display_name":"O6-methylguanine-DNA methyltransferase","score":0.8899999856948853},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8878258466720581},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8227711915969849},{"id":"https://openalex.org/C60748783","wikidata":"https://www.wikidata.org/wiki/Q2984243","display_name":"DNA mismatch repair","level":4,"score":0.6063989996910095},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5399200320243835},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.5215466022491455},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5208442807197571},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.510737419128418},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4926307797431946},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49151811003685},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4492796063423157},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4488629400730133},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.33669495582580566},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1731722354888916},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1608046293258667},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09259149432182312},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07082536816596985},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.tps2659","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.tps2659","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:iris.unito.it:2318/2010490","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2318/2010490","pdf_url":"https://iris.unito.it/bitstream/2318/2010490/1/Pembrolizumab%20in%20MMR-proficient%20metastatic%20colorectal%20cancer%20pharmacologically%20primed%20to%20trigger%20dynamic%20hypermutation%20status_%20The%20ARETHUSA%20trial.%20_%20Journal%20of%20Clinical%20Oncology.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":{"id":"pmh:oai:iris.unito.it:2318/2010490","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2318/2010490","pdf_url":"https://iris.unito.it/bitstream/2318/2010490/1/Pembrolizumab%20in%20MMR-proficient%20metastatic%20colorectal%20cancer%20pharmacologically%20primed%20to%20trigger%20dynamic%20hypermutation%20status_%20The%20ARETHUSA%20trial.%20_%20Journal%20of%20Clinical%20Oncology.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/conferenceObject"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2947553355.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4253467625","https://openalex.org/W4229017525","https://openalex.org/W4282964654","https://openalex.org/W4389241535","https://openalex.org/W4283832066","https://openalex.org/W2592074471","https://openalex.org/W3201933598","https://openalex.org/W3178645752","https://openalex.org/W4283837230","https://openalex.org/W4231061296"],"abstract_inverted_index":{"TPS2659":[0],"Background:":[1],"Metastatic":[2],"colorectal":[3],"cancer":[4],"(CRC)":[5],"harbouring":[6],"genetic":[7],"defects":[8],"in":[9,39,87,106,127,206,264],"the":[10,43,51,58,115,133,152,207,272],"mismatch-repair":[11],"pathway":[12],"(MMRd)":[13],"presents":[14],"with":[15,46,125,214,246],"a":[16,122,141],"high":[17],"tumor":[18,224,299],"mutational":[19],"burden":[20],"(TMB),":[21],"and":[22,56,62,102,192,210,242,255,258,284,296],"is":[23,140],"highly":[24],"sensitive":[25],"to":[26,72,80,119,132,169,238],"anti\u2013programmed":[27],"cell":[28],"death":[29],"protein":[30],"1":[31],"(PD-1)":[32],"immune":[33],"checkpoint":[34,81],"inhibitors.":[35,82],"We":[36,112],"recently":[37],"showed":[38,103],"preclinical":[40],"models":[41],"that":[42,67,230],"pharmacological":[44],"treatment":[45,101,174,259],"temozolomide":[47],"(TMZ)":[48],"can":[49,129],"induce":[50],"inactivation":[52],"of":[53,60,97,147,186,292,298],"MMR":[54,74,98,162],"genes,":[55],"consequently":[57],"increase":[59,105],"TMB":[61,107,218],"immunogenic":[63],"neoantigens,":[64],"thus":[65,113],"suggesting":[66],"TMZ":[68,92,126,215],"could":[69],"be":[70,159,181,212,221,244,269,276,288],"used":[71,277,289],"prime":[73],"proficient":[75],"(MMRp)":[76,178],"tumors":[77],"for":[78,161,171,184,278,290],"response":[79,249],"Accordingly,":[83],"mCRC":[84,131,155],"patients":[85,128,157,165,179,201,229,267],"recruited":[86],"previous":[88],"clinical":[89,117],"trials":[90],"where":[91],"was":[93],"administered,":[94],"acquired":[95],"alterations":[96],"genes":[99],"upon":[100],"remarkable":[104],"at":[108,226],"disease":[109],"progression":[110],"(PD).":[111],"designed":[114],"ARETHUSA":[116],"trial":[118,145,302],"test":[120],"whether":[121],"priming":[123],"course":[124],"sensitize":[130],"anti-PD1":[134],"inhibitor":[135],"pembrolizumab.":[136,247],"Methods:":[137],"Arethusa":[138],"(NCT03519412)":[139],"2-cohorts,":[142],"phase":[143,209],"II":[144],"consisting":[146],"three":[148],"different":[149],"phases.":[150],"In":[151],"SCREENING,":[153],"348":[154],"RAS-mutated":[156],"will":[158,166,180,204,211,219,231,236,243,268,275,287],"tested":[160,183],"status.":[163],"MMRd":[164,273],"proceed":[167,237],"directly":[168],"TRIAL":[170,239],"immediate":[172],"pembrolizumab":[173],"(expected":[175,202,240],"14).":[176],"MMR-proficient":[177],"further":[182],"expression":[185],"O6-methylguanine-DNA":[187],"methyltransferase":[188],"(MGMT)":[189],"by":[190,193],"immunohistochemistry":[191],"promoter":[194,198],"methylation":[195],"analysis.":[196],"IHC-negative,":[197],"methylation-positive":[199],"MMRp":[200,265],"67)":[203],"enter":[205],"PRIMING":[208],"treated":[213,245],"until":[216],"PD.":[217],"then":[220],"assessed":[222],"on":[223],"biopsies":[225],"resistance.":[227],"Those":[228],"have":[232],">":[233],"20":[234],"mutations/megabase":[235],"20)":[241],"Overall":[248,256],"rate":[250],"(primary":[251],"outcome),":[252],"Progression":[253],"Free,":[254],"Survival,":[257],"related":[260],"toxicities":[261],"(secondary":[262],"outcomes)":[263],"pembrolizumab-treated":[266],"estimated.,":[270],"while":[271],"cohort":[274],"comparison.":[279],"Tissue":[280],"biopsies,":[281],"longitudinal":[282],"blood":[283],"stool":[285],"collection":[286],"discovery":[291],"predictive":[293],"molecular":[294],"biomarkers":[295],"assessment":[297],"evolution.":[300],"Clinical":[301],"information:":[303],"NCT03519412.":[304]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2019-06-07T00:00:00"}